The development and application of nanotechnology-related knowledge and tools in
modern medicine has been showing great potentials in elevating human's living standards …

Ongoing research into the application of nanotechnology for cancer treatment and diagnosis
has demonstrated its advantages within contemporary oncology as well as its intrinsic …

The design of cancer-targeting particles with precisely tuned physicochemical properties
may enhance the delivery of therapeutics and access to pharmacological targets. However …

Ultrasmall nanoparticulate materials with core sizes in the 1-3 nm range bridge the gap
between single molecules and classical, larger-sized nanomaterials, not only in terms of …

Chimeric antigen receptor (CAR)-T cells represent a major breakthrough in cancer therapy,
wherein a patient's own T cells are engineered to recognize a tumor antigen, resulting in …

Background Fluorescent silica nanoparticles have been extensively utilised in a broad
range of biological applications and are facilitated by their predictable, well-understood …

Purpose: Small-molecule inhibitors have revolutionized treatment of certain genomically
defined solid cancers. Despite breakthroughs in treating systemic disease, central nervous …

Chemotherapeutic drug-induced acute kidney injury (AKI) involves pathologically increased
labile iron species in the kidneys that mediate the excessive generation of reactive oxygen …

Although a large body of literature exists on the potential use of nanoparticles for medical
applications, the number of probes translated into human clinical trials is remarkably small …

Small molecule-drug conjugates (SMDCs) are increasingly being considered as an
alternative to antibody-drug conjugates (ADCs) for the selective delivery of anticancer …